Indian Immunologicals Ltd (IIL), a subsidiary of National Dairy Development Board, will launch four new vaccines next year. The company is setting up a new manufacturing facility in Hyderabad with an investment of Rs 150 crore.
Announcing this in an official release, the company stated that it has plans to launch new vaccines for bovines, sheep and pets—Pentavalent vaccine for humans as well as vaccines for Japanese encephalitis, Brucellosis and Recombinant Tick vaccine in animals.
IIL is the largest veterinary vaccine manufacturer and exporter in the country and caters to nearly 80 per cent of foot and mouth (FMD) vaccine requirement. "Currently we have three manufacturing units, one in Ooty and two in Hyderabad. As per the plans the new facility in Hyderabad will be functional by mid next year. Built in an area of 50 acres the manufacturing unit will produce both human and animal vaccine. We are also in the process of launching a new improved vaccine against Brucellosis disease," said N. Anand, general manager-human health marketing, Indian Immunologicals.
